Inflation rebates to reduce Medicare payment for 34 Part B drugs

This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.

A primer on Medicare Part D prescription drug rebates: Insights

Mitigating the Inflation Reduction Act's Adverse Impacts on the

Incorporating Added Therapeutic Benefit and Domestic Reference

Medicare Drug Price Negotiation Under the Inflation Reduction Act

Inflation Reduction Act's Medicare Part B and D inflation rebates

Explaining the Prescription Drug Provisions in the Build Back

Inflation Reduction Act's Medicare Part B and D inflation rebates

Inflation Reduction Act of 2022: No Room for Negotiation - Trinity

Drug Channels: The Inflation Reduction Act: Three Unintended

Inflation Reduction Act Rebates: Changes to Medicare